Sivextro Approval History
FDA Approved: Yes (First approved June 20, 2014)
Brand name: Sivextro
Generic name: tedizolid phosphate
Dosage form: Tablets and Injection
Company: Cubist Pharmaceuticals, Inc.
Treatment for: Skin and Structure Infection
Sivextro (tedizolid phosphate) is an oxazolidinone antibiotic drug indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI).